Ann: Atomo receives TGA approval for COVID19 antibody test, page-115

@Tamaruler
Sorry, no payment if no FDA approval. Deal starts after FDA approval for the take or pay minimum qty. Here is the text:
" Once relevant regulatory authorisations or approvals are obtained..."
+
"Access Bio is obliged to sell a minimum of two million Products by 30 September 2021. If this threshold is not achieved by Access Bio within the timeframe, Access Bio is obliged to make a payment for that number of units short of two million and Access Bio's exclusive rights under the agreement in the United States, Canada and Mexico automatically become non-exclusive."
+
At1 supplies Galileo devices for free for a "...a percentage of the gross revenue from all sales..." for those 2m/yr minimum -devices.

If Access Bio make the threshold, then the deal renews, same conditions for 12mths more and so on (until they re-negotiate anything I guess for higher quantities/different sharing %).